OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
19
Results
Show all
Save search
Copy query
Show results for
Unknown
(19)
Publication Date
Release Date
2023
(5)
2024
(2)
2016
(2)
2015
(2)
2014
(2)
2022
(1)
2021
(1)
2020
(1)
2013
(1)
2012
(1)
2011
(1)
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
Six reference-quality genomes reveal evolution of bat adaptations.
Not available
S-EPMC8075899
|
biostudies-literature
Cite
REGEN-COV Antibody Combination and Outcomes in Outpatients with Covid-19.
Not available
S-EPMC8522800
|
biostudies-literature
Cite
Loss-of-function in RBBP5 results in a syndromic neurodevelopmental disorder associated with microcephaly.
Not available
S-EPMC11648989
|
biostudies-literature
Cite
Rapid Development of an Integrated Network Infrastructure to Conduct Phase 3 COVID-19 Vaccine Trials.
Not available
S-EPMC10546713
|
biostudies-literature
Cite
Sporadic visual acuity loss in the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT).
Not available
S-EPMC4301065
|
biostudies-literature
Cite
Risk of COVID-19 after natural infection or vaccination.
Not available
S-EPMC10518569
|
biostudies-literature
Cite
Thiazolidinedione use and retinal fluid in the comparison of age-related macular degeneration treatments trials.
Not available
S-EPMC10245276
|
biostudies-literature
Cite
Predominantly Persistent Intraretinal Fluid in the Comparison of Age-related Macular Degeneration Treatments Trials.
Not available
S-EPMC10282893
|
biostudies-literature
Cite
Ranibizumab and bevacizumab for neovascular age-related macular degeneration.
Not available
S-EPMC3157322
|
biostudies-literature
Cite
Macular morphology and visual acuity in the comparison of age-related macular degeneration treatments trials.
Not available
S-EPMC3737287
|
biostudies-literature
Cite
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets